Si deseas distinguir tus productos, servicios o ambos de los de otra empresa, es posible que necesites una marca o nombre comercial. Descubre qué son, en qué consiste su procedimiento de registro y qué implica.
Información sobre los plazos de presentación de solicitudes de transformación de marcas de la Unión Europea en marca nacional española. Más información
Si tienes un nuevo dispositivo, producto o procedimiento que resuelva un problema técnico o tenga una ventaja práctica, existen distintas formas de protegerlo en España y en otros países. Descubre cómo hacerlo.
¿Tu innovación reside en la estética, la ornamentación o la apariencia de tu producto? Protégela mediante un diseño industrial. Descubre qué derechos confiere el registro y cómo realizar la tramitación.
Las indicaciones geográficas protegen el nombre de un producto originario de una zona geográfica, a la cual le debe una determinada calidad, reputación u otra característica. Descubre qué son, en qué consiste su procedimiento de registro y qué beneficios conceden.
Las patentes publicadas en todo el mundo son una valiosa fuente de información científica, técnica y comercial.
Si eres emprendedor/a o una empresa y quieres potenciar y mejorar la rentabilidad de tu negocio protegiendo de forma adecuada los activos intangibles de tu organización, en este espacio encontrarás lo necesario.
472
resultados
Última actualización
31/07/2026 [07:10:00]
Resultados 425 a 450 de 472
Resumen de: WO2026139955A1
A system, including: a memory, wherein the memory stores measurements or changes thereof of a physiological parameter measured during a session of a treatment and/or following the treatment session, wherein the measurements indicate a response or changes thereof of the subject body to a sensory interface presented to the subject during the treatment session; a user interface configured to generate and deliver a human detectable indication; a control circuitry configured to: process the measurements to determine performance of the subject in the treatment session; produce a suggestion indication according to the determined performance, wherein the suggestion indication comprises information about one or more ways to maintain or improve performance of the subject in an additional session of the treatment compared to the determined performance in the treatment session; signal the user interface to generate and deliver a human detectable indication with the suggestion indication.
Resumen de: WO2026141051A1
Provided is a program capable of quickly estimating visual acuity without difficulty. This program causes a processor to function as: a display control unit for displaying, on a display unit, an object being viewed by a subject; and an estimation unit for estimating the visual acuity of the subject on the basis of eye movements of the subject when tracking the object with the eyes.
Resumen de: WO2026142001A1
An electronic apparatus according to an embodiment may cause to be identified, on the basis of biometric information, whether a first condition related to heatstroke is satisfied. The first condition may include conditions in which the skin temperature is higher than or equal to a first threshold temperature, the ratio of a heart rate to a resting heart rate is greater than or equal to a threshold ratio, and a sweat output is greater than or equal to a threshold sweat output. The electronic apparatus may cause, on the basis of the first condition being satisfied, a display to display first information indicating that a user is at risk of heatstroke.
Resumen de: US20260182928A1
0000 The present disclosure relates to a method of evaluating a neuromuscular system, the method comprising: obtaining a neuromuscular system signal; dividing the neuromuscular system signal into a plurality of segment units based on frequency; extracting a feature vector for each of the divided plurality of segments; and performing neuromuscular system condition evaluation by inputting the extracted feature vector into an artificial intelligence model trained through artificial intelligence-based model training.
Resumen de: WO2026142837A1
Aspects of the present disclosure provide techniques for detecting medication administration by one or more health management devices in a health management system. An example method performed by an analyte sensor system in the health management system includes receiving an injection of a medication via an injection port of the analyte sensor system, delivering the medication to subcutaneous tissue of a user of the analyte sensor system via a cannula coupled with the injection port, generating, using an analyte sensor of the analyte sensor system, a signal associated with an analyte concentration level of the subcutaneous tissue of the user, processing the signal to generate processed analyte sensor data, wherein the processed analyte sensor data indicates at least the analyte concentration level of the user, and transmitting the processed analyte sensor data to a display device.
Resumen de: US20260188497A1
0000 For each of a plurality of time intervals: a power spectrum is generated using a corresponding portion of EEG data; a normalized power spectrum is generated; and a preferred frequency (a frequency with a largest z-score or a highest normalized power in the normalized power spectrum corresponding to the time interval) or dominant frequency for the time interval is determined. A set of time windows is defined, each including multiple time intervals of the plurality of time intervals. For each of a set of time windows, a number of the time intervals is determined for which the preferred or dominant frequency is within a Beta band (12-30 Hz frequencies) or a portion thereof. For a time window, it is determined that an alert condition is satisfied using the number of the plurality of time intervals where the preferred or dominant frequency is within the Beta band or a portion thereof.
Resumen de: WO2026142802A1
Certain aspects of the present disclosure provide a therapy management system configured to monitor at least glucose concentration levels of a patient during a first time period using one or more glucose sensors to obtain glucose data, and determine a diabetic state classification of the patient based on the glucose data. The diabetic state classification indicates a diabetic state of the patient and comprises one of: a healthy classification, a pre-diabetic classification, a mild type 2 diabetes (T2D) classification, a severe T2D classification, or a gestational diabetes classification. The therapy management system is further configured to provide personalized feedback to the patient based on the determined diabetic state classification, wherein the personalized feedback comprises a recommendation for at least one of an exercise session, a dietary change, a lifestyle modification, a medication adjustment, or a continuous glucose monitoring wear schedule.
Resumen de: US20260183065A1
0000 Novel tools and techniques are provided for implementing intelligent assistance (“IA”) or extended intelligence (“EI”) ecosystem to placement procedures for cardiac implantable electronic device (“CIED”). In various embodiments, a computing system might analyze received one or more first layer input data (i.e., room content-based data) and received one or more second layer input data (i.e., patient and/or tool-based data), and might generate one or more recommendations for guiding a medical professional in performing a CIED placement procedure in a heart of the patient, based at least in part on the analysis, the generated one or more recommendations comprising 3D or 4D mapped guides toward, in, and around the heart of the patient. The computing system might then generate one or more XR images, based at least in part on the generated one or more recommendations, and might present the generated one or more XR images using a UX device.
Resumen de: US20260182920A1
A method for collecting weight data from an infant sleep device includes measuring weight of an infant positioned on a platform of the infant sleep device with one or more weight sensors at multiple collection instances including prior to movement of the platform, when the platform is moving, or after movement of the platform stops for a predetermined period. The method includes calibrating the one or more weight sensors upon startup and re-calibrating at regular intervals or automatically when a system weight changes when the infant is not present on the platform.
Resumen de: US20260183087A1
Determine an amount of movement between an “anterior” updated instant and a “posterior” updated instant after the anterior updated instant. At the anterior updated instant, implementing an analysis method to obtain an anterior updated item of spatial information. Analyze a set of several images to obtain spatial information. Create a historical learning database relating to a dental body and the spatial attribute, with a set of historical images all depicting the dental body and an item of spatial information.Training the neural network, by providing the sets of several historical images as input and with the historical spatial information as output, with the spatial attribute defining an ordered sequence of variables in a three-dimensional reference frame. At the posterior updated instant, implement analysis to obtain a posterior updated item of spatial information. Compare the anterior and posterior updated spatial information, to obtain an amount of movement.
Resumen de: US20260183000A1
0000 The present application describes various embodiments of guides that are designed in accordance with one or more anatomical landmarks near an operated bone (or portion thereof). In aspects, at least a portion of a guide is designed to conform to the shape of one or more anatomical landmarks in order to attach (or latch) the guide to at least one of the one or more anatomical landmarks. In aspects, the contact surface (or inner contour) of a guide may also be designed to follow at least a portion of the contour of the operated bone. The landmark-conforming and/or contour-following design of the guide may assist surgeons in the placement of the guide.
Resumen de: US20260184709A1
0000 The present disclosure provides crystalline and amorphous forms of 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(2-propanyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl)pyrido2,3-dpyrimidin-2(1H)-one, including several anhydrous, hydrate and solvate forms, and solid state forms thereof, pharmaceutical compositions, and methods of treating a disease mediated by KRAS G12C inhibition.
Resumen de: US20260183088A1
An extraoral orthopedic device (1) for the direct protraction of the maxilla and the direct or indirect protraction of the mandible, comprising: two metallic girders, one mouth girder (4), which is coupled through traction means (5) with an intraoral mechanism (6) and one connecting girder (3), which couples the said mouth girder (4) with a skeletal support wreath (2), placed and supported on the neurocranium (9) by means of its precision to the anatomy of it and the two elastic fixation straps (7) passing around the shoulders and through the axillae (8), wherein a) said skeletal support wreath (2), individually designed using the 3D digital imprint of a person's head and a computer, comprises first means of adjustment and support (12, 13, 14, 15) in order to ensure the optimal placement of the said connecting girder (3) and first means of support (17) aiming at its fixation to the neurocranium (9) by means of the straps (7), b) the said mouth girder (4) comprises first means of adjustment (25) and support (21, 22, 24) aiming at its ergonomic placement into the said connecting girder (3), thus ensuring optimal direction of the traction means (5) individualized to each person.
Resumen de: US20260183085A1
The present exemplary embodiments relate to a method and system for virtual segmentation of teeth and jaw and/or generating orthodontic appliances, using 3D models on a computer, tablet, or any similar device. It finds particular application in conjunction with magnetic orthodontic appliances or aligners, and will be described with particular reference thereto. However, it is to be appreciated that the present exemplary embodiments are also amenable to other applications, for example, where improved method of virtual segmentation, treatment simulation and/or appliance fabrication is desired in a variety of other environments.
Resumen de: US20260182963A1
0000 Providing sensory output indicating lung thickening due to congestion, infection, inflammation, and/or fibrosis in a subject are described. Sensor output signals are processed to detect areas of lung thickening and a sensory output device is controlled to generate and/or modulate sensory output for spatially localized areas of lung thickening. In some embodiments, the system uses two-dimensional video images from an ultrasound machine and generates an audio signal such as a “click” each time a B-line, the visual representation of lung edema or fibrosis, is detected on the image. During real-time ultrasound imaging of a patient's lung, the patient may hear multiple clicks with varying intensity and frequency depending on proximity to areas of lung thickening. This facilitates examination of the lung using diagnostic ultrasound with feedback that is heard rather than seen, with louder and more frequent clicks representing areas of more diseased lung.
Resumen de: US20260182952A1
0000 Proposed concepts aim to provide schemes, solutions, concepts, designs, methods and systems pertaining to predicting a remaining duration of a cardiotocograph (CTG) scanning session of a subject. In particular, CTG data and movement data of the subject during the scanning session are obtained. This data is then analysed to identify artifacts in the CTG data associated with movement of the subject. From the CTG data, movement data and artifacts, a remaining duration of the CTG scanning session can be predicted. In this way, despite the potential for signal drop-outs during the scanning session, acquisition of a sufficient amount of CTG data during the scanning session may be assured.
Resumen de: US20260183035A1
0000 An energy module is disclosed that includes a housing, a port mounted to the housing, a first emitter and a first receiver aligned with the first emitter, a second emitter and a second receiver aligned with the second emitter, and a control circuit in operable communication with the first emitter, the first receiver, the second emitter, and the second receiver. The control circuit is operable to emit a first beam from the first emitter toward the first receiver, emit a second beam from the second emitter toward the second receiver, and determine a type of surgical instrument coupled to the port based on the first receiver receiving or failing to receive the first beam and the second receiver receiving or failing to receive the second beam.
Resumen de: US20260182870A1
0000 Techniques disclosed herein relate to food analysis and glucose level management. In some examples, the techniques involve determining a consumption of a food item by a user, receiving data indicative of a glucose level of the user, determining an effect of the food item on the glucose level of the user based on a change of the glucose level of the user, and storing the effect of the food item on the glucose level of the user that includes data associated with one or more effects of the food item on the glucose level of the user.
Resumen de: AU2026204455A1
Methods for selecting a cancer patient for immunotherapy comprise establishing a total passenger gene mutation burden from a tumor of a cancer patient, generating a background distribution for the mutational burden of the tumor, normalizing the total passenger gene mutation burden against the background distribution, and categorizing the cancer patient as an immunotherapy responder when the total passenger gene mutation burden is greater than the mean of the background distribution. When the cancer patient is an immunotherapy responder, the patient may be administered an immunotherapy regimen that comprises activation/inhibition of T cell receptors that promote T cell activation and/or prolong immune cytolytic activities. un u n e t h o d s f o r s e l e c t i n g a c a n c e r p a t i e n t f o r i m m u n o t h e r a p y c o m p r i s e e s t a b l i s h i n g a t o t a l p a s s e n g e r g e n e m u t a t i o n b u r d e n f r o m a t u m o r o f a c a n c e r p a t i e n t , g e n e r a t i n g a b a c k g r o u n d d i s t r i b u t i o n f o r t h e m u t a t i o n a l b u r d e n o f t h e t u m o r , n o r m a l i z i n g t h e t o t a l p a s s e n g e r g e n e m u t a t i o n b u r d e n a g a i n s t t h e b a c k g r o u n d d i s t r i b u t i o n , a n d c a t e g o r i z i n g t h e c a n c e r p a t i e n t a s a n i m m u n o t h e r a p y r e s p o n d e r w h e n t h e t o t a l p a s s e n g e r g e n e m u t a t i o n b u r d e n i s g r e a t e r t h a
Resumen de: US20260182868A1
Embodiments that compensate for changes to sensor response characteristics (e.g., sensitivity) due to time durations are disclosed. The time durations can be the amount of time the sensor is in a post-manufacture packaged state prior to use, or the amount of time the sensor is in use. Sensor response changes due to other variables can also be compensated for.
Resumen de: US20260182947A1
0000 A method of controlling an X-ray system can include placing a breast of a patient into a breast compression assembly including a breast positioning area. Denseness of tissue of the breast is measured using an absorption contrast imaging apparatus, and the results are transmitted to a work-station. The absorption contrast imaging measurement results are processed using the work-station to determine coordinates of potential cancer sites in the tissue. The absorption contrast imaging apparatus is moved away from the breast positioning area, and a diffractometer is moved into the breast positioning. Measurements are performed at the coordinates of the potential cancer sites using a diffractometer, and the results are transmitted to the work-station. The obtained diffractometer measurement results are processed using the work-station to perform analysis of the diffractometer measurement results, and to perform diagnostics using the analyzed diffractometer measurement results.
Resumen de: WO2024015911A1
In one aspect, build materials for use with a three-dimensional (3D) printing system are described herein. In some embodiments, a build material described herein comprises an acrylate component, a photoinitiator component, a non-curable absorber component, and water. The photoinitiator component of the build material is operable to initiate curing of the acrylate component and/or other curable materials that may optionally be present when the photoinitiator is exposed to incident curing radiation having a Gaussian distribution of wavelengths and a peak wavelength λ. The build material has a penetration depth (Dp) and a critical energy (Ec) at the wavelength λ. In some embodiments, the Dp is greater than 200 μm and less than 300 μm, and the Ec is 3-1 2 mj/cm2. In other embodiments, the Dp is greater than 10 μm and less than 50 μm, and the Ec is 5-40 mj/cm2.
Resumen de: US20260182938A1
0000 A breast rest for a mammography device includes a front panel on a patient-facing side of the breast rest and a top panel having a concavity configured to accommodate a breast of a patient. A transition from the front panel to the top panel can be curved. The breast rest can be included in the mammography device. The breast rest can further include side panels. The breast rest can further include an open end to receive a breast test instrument. Multiple sizes and/or shapes of the breast rest can be provided and selected from based on patient data. Breast rests can be manufactured for particular patients having sizes and/or shapes determined from patient data.
Resumen de: US20260182911A1
0000 The present application provides embodiments of exoskeletons, methods of controlling thereof, and tremor simulator devices. According to an embodiment, there is provided an exoskeleton. The exoskeleton comprises a first support; a second support; a joint structure rotatably connecting the first support and the second support; and a controller. The second support comprises: a first anchor component connecting to the joint structure, a second anchor component, and a sensor coupled to the controller, wherein the first anchor component and the second anchor component are connected by a variable stiffness unit coupled to the controller, and wherein the variable stiffness unit is configured to provide a variable damping force determined by the controller to reduce an amplitude of a tremor sensed by the sensor.
Nº publicación: US20260182894A1 02/07/2026
Solicitante:
ENCHANNEL MEDICAL LTD [US]
ENCHANNEL MEDICAL, LTD.
Resumen de: US20260182894A1
0000 Methods of generating a graphical representation of cardiac information on a display screen are provided. The method comprises: electronically creating or acquiring an anatomical model of the heart including multiple cardiac locations; electronically determining a data set of source information corresponding to cardiac activity at the multiple cardiac locations; electronically rendering the data set of source information in relation to the multiple cardiac locations on the display screen. Systems and devices for providing a graphical representation of cardiac information are also provided.
BOPI
Sede Electrónica
